{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:28:23Z","timestamp":1788906503202,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.cyto.2007.12.007","type":"journal-article","created":{"date-parts":[[2008,3,2]],"date-time":"2008-03-02T12:27:53Z","timestamp":1204460873000},"page":"315-321","source":"Crossref","is-referenced-by-count":35,"title":["Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immunosuppressive therapy"],"prefix":"10.1016","volume":"41","author":[{"given":"Derin B.","family":"Keskin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel N.H.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masha","family":"Fridkis-Hareli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Razzaque Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2007.12.007_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0190-9622(79)80050-X","article-title":"Pemphigus and pemphigoid","volume":"1","author":"Lever","year":"1979","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib2","first-page":"704","article-title":"A review of mucocutaneous disorders affecting the mouth and lips","volume":"28","author":"Scully","year":"1999","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.cyto.2007.12.007_bib3","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0025-7125(05)70415-6","article-title":"The blistering diseases","volume":"82","author":"Scott","year":"1998","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.cyto.2007.12.007_bib4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(99)03007-X","article-title":"Pemphigus and bullous pemphigoid","volume":"354","author":"Nousari","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2007.12.007_bib5","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0190-9622(88)70128-0","article-title":"Pemphigus","volume":"18","author":"Korman","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1532-5415.1998.tb01020.x","article-title":"Pemphigus vulgaris in older adults","volume":"461","author":"Tehranchi-Nia","year":"1998","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.cyto.2007.12.007_bib7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/archderm.116.9.1035","article-title":"Pemphigus in Hartford County, Connecticut, from 1972 to 1977","volume":"1169","author":"Simon","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2340\/0001555562491496","article-title":"Pemphigus: an epidemiological study of patients treated in Finnish hospitals between 1969 and 1978","volume":"62","author":"Hietanen","year":"1982","journal-title":"Acta Derm Venerol"},{"key":"10.1016\/j.cyto.2007.12.007_bib9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1440-0960.2001.00509.x","article-title":"Comparative study of pemphigus vulgaris and pemphigus foliaceus in Singapore","volume":"42","author":"Goon","year":"2001","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-4362.1979.tb04683.x","article-title":"Pemphigus in El Salvador. An eight-year study (1970\u20131977)","volume":"18","author":"Hernandez-Perez","year":"1979","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0030-4220(74)90365-X","article-title":"Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion","volume":"38","author":"Pisanti","year":"1974","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.cyto.2007.12.007_bib12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/jama.282.6.572","article-title":"Pemphigus diseases of anti-desmosomal autoimmunity","volume":"282","author":"Udey","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.cyto.2007.12.007_bib13","series-title":"Fitzpatrick\u2019s Dermatology in General Medicine","first-page":"558","article-title":"Pemphigus","author":"Stanley","year":"2003"},{"key":"10.1016\/j.cyto.2007.12.007_bib14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0738-081X(00)00190-5","article-title":"Therapy of pemphigus","volume":"19","author":"Toth","year":"2001","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib15","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/S0161-6420(99)90496-7","article-title":"Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study","volume":"106","author":"Foster","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.cyto.2007.12.007_bib16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1067\/mjd.2000.107248","article-title":"Cicatricial pemphigoid","volume":"43","author":"Fleming","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0733-8635(05)70006-1","article-title":"Immunosuppressive agents in dermatology. An update","volume":"16","author":"Dutz","year":"1998","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.cyto.2007.12.007_bib18","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1067\/mjd.2001.116339","article-title":"Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment","volume":"45","author":"Ahmed","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0190-9622(87)70069-3","article-title":"Azathioprine in the treatment of pemphigus vulgaris: a long-term follow-up","volume":"16","author":"Aberer","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0190-9622(87)70226-6","article-title":"Use of cyclophosphamide in azathioprine failures in pemphigus","volume":"17","author":"Ahmed","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib21","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0190-9622(84)80463-6","article-title":"Pemphigus vulgaris: results of treatment with gold as a steroid sparing agent in a series of thirteen patients","volume":"11","author":"Poulin","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib22","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archderm.134.9.1104","article-title":"Treatment of pemphigus with gold","volume":"134","author":"Pandya","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib23","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archderm.135.10.1275","article-title":"Methotrexate as an adjuvant treatment for pemphigus vulgaris","volume":"135","author":"Smith","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0190-9622(00)90014-8","article-title":"The use of chlorambucil with prednisone in the treatment of pemphigus","volume":"42","author":"Shah","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib25","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0190-9622(08)81506-X","article-title":"The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study","volume":"30","author":"Lapidoth","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib26","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0190-9622(88)70132-2","article-title":"Treatment of nine cases of pemphigus vulgaris with cyclosporine","volume":"18","author":"Barthelemy","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1365-2230.1998.00323.x","article-title":"Pemphigus vulgaris treated with combined oral cyclosporin and cyclophosphamide","volume":"23","author":"Sato","year":"1998","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2133.1999.02952.x","article-title":"Successful treatment of severe refractory atopic dermatitis with mycophenolate mofetil","volume":"141","author":"Grundmann-Kollmann","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib29","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/archderm.123.6.783","article-title":"Dapsone as initial treatment in superficial pemphigus: report of nine cases","volume":"123","author":"Basset","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-4362.1999.00624.x","article-title":"Pemphigus vulgaris: benefits of tetracycline as adjuvant therapy in a series of thirteen patients","volume":"38","author":"Calebotta","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1440-0960.1996.tb01013.x","article-title":"Minocycline is a useful adjuvant therapy of pemphigus","volume":"37","author":"Gaspar","year":"1996","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archderm.132.2.203","article-title":"The adjuvant therapy of pemphigus","volume":"132","author":"Bystryn","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-4362.1995.tb04450.x","article-title":"Steroid-pulse therapy in pemphigus vulgaris long term follow-up","volume":"34","author":"Chryssomallis","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib34","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1365-4362.1995.tb04430.x","article-title":"Dexamethasone-cyclophosphamide pulse therapy for pemphigus","volume":"34","author":"Pasricha","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib35","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/archderm.124.11.1659","article-title":"Controlled study of plasma exchange in pemphigus","volume":"124","author":"Guillaume","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2340\/0001555575150152","article-title":"The steroid-sparing effect of long-term plasmapheresis in pemphigus","volume":"75","author":"Sondergaard","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.cyto.2007.12.007_bib37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000018090","article-title":"Short-time extracorporeal photochemotherapy in the treatment of drug-resistant autoimmune bullous diseases","volume":"198","author":"Wollina","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.cyto.2007.12.007_bib38","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1067\/mjd.2000.108366","article-title":"Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris","volume":"43","author":"Engineer","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib39","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2007.12.007_bib40","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.intimp.2005.11.018","article-title":"Use of intravenous immunoglobulin therapy in autoimmune blistering diseases","volume":"6","author":"Ahmed","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.cyto.2007.12.007_bib41","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.intimp.2005.11.013","article-title":"Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanisms","volume":"6","author":"Bayary","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.cyto.2007.12.007_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-065X.1994.tb00855.x","article-title":"Pooled human IgG modulates cytokine production in lymphocytes and monocytes","volume":"139","author":"Andersson","year":"1994","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cyto.2007.12.007_bib43","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7326\/0003-4819-126-9-199705010-00008","article-title":"Intravenous immune globulin therapy for neurologic diseases","volume":"126","author":"Dalakas","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cyto.2007.12.007_bib44","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1006\/clim.2001.5061","article-title":"Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production","volume":"100","author":"Bhol","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.cyto.2007.12.007_bib45","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/eji.1830250521","article-title":"Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin)","volume":"25","author":"Ruiz de Souza","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2007.12.007_bib46","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1212\/WNL.52.9.1833","article-title":"IV immunoglobulin reduces circulating proinflammatory cytokines in Guillain\u2013Barre syndrome","volume":"52","author":"Sharief","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2007.12.007_bib47","first-page":"383","article-title":"Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumor necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity","volume":"8","author":"D\u2019Auria","year":"1997","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.cyto.2007.12.007_bib48","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s004030050421","article-title":"Increased serum interleukin-15 levels in bullous skin diseases: correlation with disease intensity","volume":"291","author":"D\u2019Auria","year":"1999","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.cyto.2007.12.007_bib49","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000063895","article-title":"Cytokine pattern in blister fluid and sera of patients with pemphigus","volume":"205","author":"Baroni","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.cyto.2007.12.007_bib50","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1006\/cyto.1999.0642","article-title":"Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid","volume":"12","author":"Bhol","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2007.12.007_bib51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1523-1747.2000.00835.x","article-title":"In vitro and in vivo expression of interleukin-1alpha and tumor necrosis factor-alpha mRNA in pemphigus vulgaris: interleukin-1alpha and tumor necrosis factor-alpha are involved in acantholysis","volume":"114","author":"Feliciani","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib52","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0190-9622(82)70111-2","article-title":"Death in pemphigus","volume":"7","author":"Ahmed","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib53","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0190-9622(00)90213-5","article-title":"Patterns of remission in pemphigus vulgaris","volume":"42","author":"Herbst","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib54","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1073\/pnas.89.8.3325","article-title":"Human autoantibodies reactive with synthetic autoantigens from T-cell receptor \u03b2 chain","volume":"89","author":"Marchalonis","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2007.12.007_bib55","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1182\/blood.V91.6.2054","article-title":"Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations","volume":"91","author":"Svenson","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2007.12.007_bib56","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0167-5699(98)01252-3","article-title":"High-avidity autoantibodies to cytokines","volume":"19","author":"Bendtzen","year":"1998","journal-title":"Immunol Today"},{"key":"10.1016\/j.cyto.2007.12.007_bib57","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2249.1993.tb03407.x","article-title":"Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg)","volume":"92","author":"Vassilev","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cyto.2007.12.007_bib58","first-page":"269","article-title":"Anti-CD4 activity of normal human immunoglobulins G for therapeutic use (intravenous immunoglobulin, IVIg)","volume":"1","author":"Hurez","year":"1994","journal-title":"Ther Immunol"},{"key":"10.1016\/j.cyto.2007.12.007_bib59","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1172\/JCI118488","article-title":"Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use (IVIg)","volume":"97","author":"Kaveri","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2007.12.007_bib60","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1182\/blood.V93.11.3624","article-title":"Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg)","volume":"93","author":"Vassilev","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2007.12.007_bib61","doi-asserted-by":"crossref","first-page":"7606","DOI":"10.4049\/jimmunol.166.12.7606","article-title":"Antibodies to C\u2013C chemokine receptor 5 in normal human IgG block infection of macrophages and lymphocytes with primary R5-tropic strains of HIV-1","volume":"166","author":"Bouhlal","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2007.12.007_bib62","doi-asserted-by":"crossref","first-page":"14210","DOI":"10.1073\/pnas.0402183101","article-title":"Natural antibodies sustain differentiation and maturation of human dendritic cells","volume":"101","author":"Bayry","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2007.12.007_bib63","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.4049\/jimmunol.161.7.3781","article-title":"Therapeutic preparations of normal polyspecific immunoglobulin G (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway","volume":"161","author":"Prasad","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2007.12.007_bib64","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.cyto.2007.12.007_bib65","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jaci.2003.09.045","article-title":"Concurrent presence of agonistic and antagonistic anti-CD95 autoantibodies in intravenous Ig preparations","volume":"112","author":"Altznauer","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cyto.2007.12.007_bib66","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1006\/bbrc.1999.1592","article-title":"Phosphorylation of Bcl-2 and mitochondrial changes are associated with apoptosis of lymphoblastoid cells induced by normal immunoglobulin","volume":"264","author":"Sooryanarayana","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cyto.2007.12.007_bib67","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood-2002-05-1447","article-title":"Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin","volume":"101","author":"Bayry","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2007.12.007_bib68","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1126\/science.1099688","article-title":"Immunotherapy: bewitched, bothered, and bewildered no more","volume":"305","author":"Steinman","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.cyto.2007.12.007_bib69","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ncprheum0481","article-title":"Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action","volume":"5","author":"Bayry","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.cyto.2007.12.007_bib70","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"17","author":"Ahmed","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2007.12.007_bib71","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/ncpneuro0429","article-title":"Shortage of human intravenous immunoglobulin\u2014reasons and possible solutions","volume":"3","author":"Bayry","year":"2007","journal-title":"Nat Clin Pract Neurol"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466607005297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466607005297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:58:10Z","timestamp":1708649890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466607005297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S1043466607005297"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2007.12.007","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}